Can Surgeons Improve Survival in Stage IV Melanoma?
Publication/Presentation Date
4-1-2008
Abstract
Successful systemic management of stage IV melanoma continues to be elusive because of the paucity of effective therapies. This has fueled the continued interest in surgical resection. Several single-institution studies and a current, large, multi-institutional phase III trial have demonstrated a survival benefit for patients who underwent surgical resection for melanoma metastases. Incorporating these results into new approaches using multimodality treatment may enhance survival in patients with stage IV melanoma.
Volume
97
Issue
5
First Page
462
Last Page
468
ISSN
0022-4790
Published In/Presented At
Mosca, P. J., Teicher, E., Nair, S. P., & Pockaj, B. A. (2008). Can surgeons improve survival in stage IV melanoma?.Journal Of Surgical Oncology, 97(5), 462-468. doi:10.1002/jso.20950
Disciplines
Hematology | Medical Sciences | Medicine and Health Sciences | Oncology
PubMedID
18270974
LVHN link
http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=18270974&site=ehost-live&scope=site
Peer Reviewed for front end display
Peer-Reviewed
Department(s)
Department of Medicine, Hematology-Medical Oncology Division, Department of Medicine Faculty
Document Type
Article